Eaton Vance Worldwide Health Sciences Fund Class A ETHSX

Morningstar Medalist Rating
  • NAV / 1-Day Return$15.09  /  +0.07%
  • Fund Size$852.2M
  • Adjusted Expense Ratio1.180%
  • Net Expense Ratio1.130%
  • Fee Level: DistributionBelow Average
  • Share Class TypeFront Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Large Value
  • Minimum Initial Investment$1,000
  • Investment StatusOpen
  • TTM Yield0.46%
  • Turnover Ratio30%

Morningstar’s Analysis ETHSX

Will ETHSX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Not a standout health strategy at this point.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Eaton Vance Worldwide Health Sciences does not have any notable advantages over its rivals, and the strategy retains its Average People and Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ETHSX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings59.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.4296M
Healthcare

AbbVie Inc

7.5759M
Healthcare

Johnson & Johnson

7.3957M
Healthcare

Merck & Co Inc

6.0747M
Healthcare

Roche Holding AG

5.2541M
—

UnitedHealth Group Inc

5.1740M
Healthcare

AstraZeneca PLC

4.4535M
Healthcare

Bristol-Myers Squibb Co

4.1232M
Healthcare

Vertex Pharmaceuticals Inc

3.8130M
Healthcare

Thermo Fisher Scientific Inc

3.5828M
Healthcare

Sponsor Center